CAREERS AT BIOMARIN
Our focus on rare disease gives us the rare opportunity to truly impact lives.
Learn More about careers with BioMarin ⌃
OUR MOTIVATION
We are inspired and driven everyday by stories like Sheri’s.
Learn More about Sheri ⌃
Patient & Community Support
Treatment is only the beginning.
We are committed to the communities we treat beyond the therapies
OUR PIPELINE
We take on the biggest challenges in rare disease.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it
-
June 15, 2021BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference
-
May 27, 2021BioMarin to Participate in Two Upcoming Virtual Investor Conferences
-
May 24, 2021European Medicines Agency Grants BioMarin’s Request for Accelerated Assessment of Valoctocogene Roxaparvovec for Treatment of Severe Hemophilia A
-
May 19, 2021BioMarin Provides Highlights of 5 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec with the Longest Duration of Clinical Experience for a Gene Therapy in Hemophilia A
-
May 18, 2021BioMarin to Participate in Two Upcoming Virtual Investor Conferences
-
May 12, 2021BioMarin Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting
-
May 3, 2021BioMarin to Participate in Two Upcoming Virtual Investor Conferences
-
April 29, 2021BioMarin Announces First Quarter 2021 Financial Results and Corporate Updates